Tapewire

Nasdaq · USD

IART

INTEGRA LIFESCIENCES HOLDINGS CORP

Export transactions ↓
Tapewire entity
2707
SEC CIK
0000917520
Parsed reports
472

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 13, 2019 Filed Mar 15, 2019 21:17 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 9,250 $0.00 Strike: $21.97 $0.00
Disclosure

SEC source: 0001209191-19-019753 · doc4.xml · derivative · entry 7

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,878

Underlying: Common Stock · 9,250 shares

Expires 2019-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/17/2011

F2 · balance_after: This option was previously reported as covering 4,431 shares at an exercise price of $50.78 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 4,625 shares of common stock at an exercise price of $43.93 per share.

F3 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:17 UTC SaleCommon Stock 20,878 $56.06 $1,170,406.07
Disclosure

SEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 4

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,134

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:17 UTC Exercise / conversionCommon Stock 20,878 $21.97 $458,585.27
Disclosure

SEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 3

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:17 UTC SaleCommon Stock 9,250 $56.06 $518,548.53
Disclosure

SEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 2

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,134

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:17 UTC Exercise / conversionCommon Stock 9,250 $21.97 $203,176.25
Disclosure

SEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 1

CARUSO RICHARD E · CIK 0001187576 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,384

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:18 UTC
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
GrantNon-Qualified Stock Option (right to buy) · Derivative 20,678 $0.00 Strike: $55.91 $0.00
Disclosure

SEC source: 0001209191-19-019754 · doc4.xml · derivative · entry 8

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,678

Underlying: Common Stock · 20,678 shares

Expires 2027-03-13

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, and third anniversaries of the grant date of 3/13/2019.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:18 UTC
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 718 $55.91 $40,143.38
Disclosure

SEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 5

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,231

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:18 UTC
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 856 $55.91 $47,858.96
Disclosure

SEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 4

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,949

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:18 UTC
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
GrantCommon Stock 4,621 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 3

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,805

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:18 UTC
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 1,191 $55.91 $66,588.81
Disclosure

SEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 2

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,184

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:18 UTC
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 2,232 $55.91 $124,791.12
Disclosure

SEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 1

Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,375

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:16 UTC
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
GrantNon-Qualified Stock Option (right to buy) · Derivative 3,795 $0.00 Strike: $55.91 $0.00
Disclosure

SEC source: 0001209191-19-019751 · doc4.xml · derivative · entry 8

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,795

Underlying: Common Stock · 3,795 shares

Expires 2027-03-13

F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2019.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:16 UTC
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
GrantCommon Stock 848 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 5

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,050

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:16 UTC
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
Tax withholdingCommon Stock 94 $55.91 $5,255.54
Disclosure

SEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 4

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,202

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:16 UTC
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
Tax withholdingCommon Stock 117 $55.91 $6,541.47
Disclosure

SEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 3

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,296

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:16 UTC
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
Tax withholdingCommon Stock 208 $55.91 $11,629.28
Disclosure

SEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 2

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,413

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:16 UTC
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
Tax withholdingCommon Stock 437 $55.91 $24,432.67
Disclosure

SEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 1

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,621

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:15 UTC
Arduini Peter JDirector · President & CEO
GrantRestricted Stock Units/Contract Stock · Derivative 20,390 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-19-019749 · doc4.xml · derivative · entry 13

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 505,118

Underlying: Common Stock · 20,390 shares

Expires not disclosed

F4 · derivative.exercise_price: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2019 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

F4 · derivative.exercise_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2019 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

F4 · derivative.expiration_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2019 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:15 UTC
Arduini Peter JDirector · President & CEO
Exercise / conversionRestricted Stock Units/Contract Stock · Derivative 258 $55.91 Strike: $0.00 $14,424.78
Disclosure

SEC source: 0001209191-19-019749 · doc4.xml · derivative · entry 12

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 484,728

Underlying: Common Stock · 258 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/18 of which the first installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.

F3 · derivative.exercise_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/18 of which the first installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.

F3 · derivative.expiration_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/18 of which the first installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:15 UTC
Arduini Peter JDirector · President & CEO
Exercise / conversionRestricted Stock Units/Contract Stock · Derivative 290 $55.91 Strike: $0.00 $16,213.90
Disclosure

SEC source: 0001209191-19-019749 · doc4.xml · derivative · entry 11

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 484,986

Underlying: Common Stock · 290 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/17 of which the second installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.

F2 · derivative.exercise_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/17 of which the second installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.

F2 · derivative.expiration_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/17 of which the second installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:15 UTC
Arduini Peter JDirector · President & CEO
GrantNon-Qualified Stock Option (right to buy) · Derivative 91,249 $0.00 Strike: $55.91 $0.00
Disclosure

SEC source: 0001209191-19-019749 · doc4.xml · derivative · entry 10

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,249

Underlying: Common Stock · 91,249 shares

Expires 2027-03-13

F1 · derivative.exercise_date: The grant will vest as to one-third of the shares on the first anniversary of the grant date of 3/13/2019 and thereafter in monthly installments through the following twenty-four months.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:15 UTC
Arduini Peter JDirector · President & CEO
Tax withholdingCommon Stock 11,687 $55.91 $653,420.17
Disclosure

SEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 6

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,309

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:15 UTC
Arduini Peter JDirector · President & CEO
Tax withholdingCommon Stock 6,215 $55.91 $347,480.65
Disclosure

SEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 5

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,996

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:15 UTC
Arduini Peter JDirector · President & CEO
Tax withholdingCommon Stock 258 $55.91 $14,424.78
Disclosure

SEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 4

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,211

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:15 UTC
Arduini Peter JDirector · President & CEO
Exercise / conversionCommon Stock 258 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 3

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,469

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:15 UTC
Arduini Peter JDirector · President & CEO
Tax withholdingCommon Stock 290 $55.91 $16,213.90
Disclosure

SEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,211

Read SEC document
March 13, 2019 Filed Mar 15, 2019 21:15 UTC
Arduini Peter JDirector · President & CEO
Exercise / conversionCommon Stock 290 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,501

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2019 Filed Mar 5, 2019 21:33 UTC
Schwartz EricCorp VP, Gen Counsel & Sec
GrantCommon Stock 17,851 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-016527 · doc4.xml · nonDerivative · entry 1

Schwartz Eric · CIK 0001329100 · Corp VP, Gen Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,586

Read SEC document
February 17, 2019 Filed Feb 20, 2019 23:15 UTC Tax withholdingCommon Stock 34 $51.06 $1,736.04
Disclosure

SEC source: 0001209191-19-011762 · doc4.xml · nonDerivative · entry 2

BRADLEY KEITH · CIK 0001188650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,444

Read SEC document
February 17, 2019 Filed Feb 20, 2019 23:15 UTC Tax withholdingCommon stock 7 $51.06 $357.42
Disclosure

SEC source: 0001209191-19-011762 · doc4.xml · nonDerivative · entry 1

BRADLEY KEITH · CIK 0001188650 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,478

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:16 UTC
Evoli LisaChief Human Resources Officer
GrantCommon Stock 874 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011198 · doc4.xml · nonDerivative · entry 3

Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,283

F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:16 UTC
Evoli LisaChief Human Resources Officer
GrantCommn Stock 1,389 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011198 · doc4.xml · nonDerivative · entry 2

Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,409

F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:16 UTC
Evoli LisaChief Human Resources Officer
GrantCommon Stock 1,206 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011198 · doc4.xml · nonDerivative · entry 1

Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,020

F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:11 UTC
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
GrantCommon Stock 604 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011192 · doc4.xml · nonDerivative · entry 3

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,058

F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:11 UTC
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
GrantCommon Stock 1,263 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011192 · doc4.xml · nonDerivative · entry 2

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,454

F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:11 UTC
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
GrantCommon Stock 1,332 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011192 · doc4.xml · nonDerivative · entry 1

Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,191

F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:09 UTC
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
GrantCommon Stock 1,470 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011190 · doc4.xml · nonDerivative · entry 3

REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,108

F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:09 UTC
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
GrantCommon Stock 2,125 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011190 · doc4.xml · nonDerivative · entry 2

REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,638

F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:09 UTC
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
GrantCommon Stock 1,497 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011190 · doc4.xml · nonDerivative · entry 1

REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,513

F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:05 UTC
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
GrantCommon Stock 1,641 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011174 · doc4.xml · nonDerivative · entry 3

DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,761

F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:05 UTC
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
GrantCommon Stock 3,541 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011174 · doc4.xml · nonDerivative · entry 2

DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,120

F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:05 UTC
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
GrantCommon Stock 3,759 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011174 · doc4.xml · nonDerivative · entry 1

DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,579

F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:07 UTC
OGRADY JUDITHCorpVP,Global Reg.Affairs
GrantCommon Stock 320 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011183 · doc4.xml · nonDerivative · entry 3

OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,113

F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:07 UTC
OGRADY JUDITHCorpVP,Global Reg.Affairs
GrantCommon Stock 708 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011183 · doc4.xml · nonDerivative · entry 2

OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,793

F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:07 UTC
OGRADY JUDITHCorpVP,Global Reg.Affairs
GrantCommon Stock 801 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011183 · doc4.xml · nonDerivative · entry 1

OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,085

F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 21:58 UTC
VINHAIS JOSEPHCorp VP, Global Qlty Assurance
GrantCommon Stock 485 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011140 · doc4.xml · nonDerivative · entry 3

VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,308

F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 21:58 UTC
VINHAIS JOSEPHCorp VP, Global Qlty Assurance
GrantCommon Stock 850 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011140 · doc4.xml · nonDerivative · entry 2

VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,823

F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 21:58 UTC
VINHAIS JOSEPHCorp VP, Global Qlty Assurance
GrantCommon Stock 972 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011140 · doc4.xml · nonDerivative · entry 1

VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,973

F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 21:56 UTC
Mosebrook JeffreyPrincipal Accounting Officer
GrantCommon Stock 330 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011136 · doc4.xml · nonDerivative · entry 2

Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,467

F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date.

Read SEC document
February 14, 2019 Filed Feb 19, 2019 21:56 UTC
Mosebrook JeffreyPrincipal Accounting Officer
GrantCommon Stock 654 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-011136 · doc4.xml · nonDerivative · entry 1

Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,137

F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.